Cytosorbents (CTSO) Non-Current Debt (2016 - 2026)

Cytosorbents' Non-Current Debt history runs 10 years deep, the most recent figure standing at $10.3 million for Q1 2026.

• Quarterly Non-Current Debt fell 27.31% year-over-year to $10.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.3 million (down 27.31% YoY) and the FY2025 annual result came in at $16.7 million, up 19.08% from the prior year.
• Non-Current Debt was $10.3 million for Q1 2026 at Cytosorbents, down from $16.7 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $16.7 million in Q4 2025 and bottomed at $1.9 million in Q1 2024.
• A 5-year average of $9.7 million and a median of $12.0 million in 2024 frame the typical range for Non-Current Debt.
• Annual changes were most pronounced in 2024 — Non-Current Debt sank 61.51% — and 2025, when it jumped 635.61%.
• Cytosorbents' Non-Current Debt stood at $5.0 million in 2022, then tumbled by 49.14% to $2.5 million in 2023, then soared by 450.4% to $14.0 million in 2024, then climbed by 19.08% to $16.7 million in 2025, then sank by 38.12% to $10.3 million in 2026.
• Business Quant data shows CTSO's Non-Current Debt at $10.3 million in Q1 2026, $16.7 million in Q4 2025, and $14.6 million in Q3 2025.